MBM-17 Catalog No.:M23695-C InChi: InChI=1S/C21H20N4O2S/c1-13(8-14-4-3-5-16(9-14)27-2)21(26)23-15-6-7-17-18(10-15)25-20(24-17)19-11-28-12-22-19/h3-7

InChi: InChI=1S/C21H20N4O2S/c1-13(8-14-4-3-5-16(9-14)27-2)21(26)23-15-6-7-17-18(10-15)25-20(24-17)19-11-28-12-22-19/h3-7

Smiles: CC(=O)C1C(=O)C=C(C)OC1=O

) produces a biphasic response in blood pressure in inactin-anesthetized rats[3]

25 mg/mL (127

COC1=CC=CC=C1OCC(O)CN1CCN(CC(=O)NC2C(C)=CC=CC=2C)CC1

MBM-17 Catalog No.:M23695-C InChi: InChI=1S/C21H20N4O2S/c1-13(8-14-4-3-5-16(9-14)27-2)21(26)23-15-6-7-17-18(10-15)25-20(24-17)19-11-28-12-22-19/h3-7MBM 17 is a potent NIMA related kinase 2 (Nek2) inhibitor with an IC50 of 3 nM. It effectively inhibits the proliferation of cancer cells by inducing cell cycle arrest and apoptosis. MBM 55 shows antitumor activities, and no obvious toxicity to mice. Product information CAS Number: 2083621 90 1 Molecular Weight: 480. 56 Formula: C28H28N6O2 Chemical Name: 2 (benzyloxy) 4 (7 {1 [2 (dimethylamino)ethyl] 1H pyrazol 4 yl}imidazo[1,2 a]pyridin 3